AEON Biopharma Inc. (AEON)
NASDAQ: AEON
· Real-Time Price · USD
0.80
0.02 (2.56%)
At close: Aug 15, 2025, 3:59 PM
0.80
-0.62%
After-hours: Aug 15, 2025, 07:50 PM EDT
AEON Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q4 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 10.45M | 13K | 537K | 3.44M | 1.56M | 16.18M | 9.75M | 5.13M | 10.61M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 29K | 29K | 29K | 29K | 29K | 29K | 34K | 360K | 1.34M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.44M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.88M | 1.58M | 1.83M | 577K | 940K | 734K | 92K | 26K | n/a |
Total Current Assets | 12.32M | 1.59M | 2.37M | 4.02M | 2.5M | 16.91M | 9.84M | 5.15M | 17.45M |
Property-Plant & Equipment | 1.45M | 1.52M | 1.6M | 1.69M | 505K | 679K | 906K | 922K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.48M | 1.55M | 1.63M | 1.72M | 534K | 708K | 940K | 1.28M | 1.34M |
Total Assets | 13.8M | 3.14M | 4M | 5.73M | 3.03M | 17.62M | 10.78M | 6.44M | 18.8M |
Account Payables | 2.44M | 5.91M | 4.63M | 3.03M | 6.52M | 4.01M | 7.8M | 1.19M | 2.32M |
Deferred Revenue | n/a | n/a | n/a | n/a | 6.23M | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 70.87M | 15.6M | n/a |
Other Current Liabilities | 429K | 1.07M | 1.56M | 1.25M | -1.89M | 1.02M | 1.11M | 1.07M | 684K |
Total Current Liabilities | 8.64M | 14.15M | 10.73M | 10.43M | 15.96M | 14.18M | 82.57M | 20.8M | 8.84M |
Long-Term Debt | 13.32M | 11.69M | 15.17M | 13.29M | 5.09M | n/a | 60.43M | 70.76M | 79.34M |
Other Long-Term Liabilities | 2.08M | 4.73M | 8.99M | 8.7M | 180.37M | 125.13M | 137.95M | 138.17M | 138.27M |
Total Long-Term Liabilities | 16.48M | 17.56M | 25.37M | 23.25M | 185.46M | 125.18M | 198.62M | 209.46M | 217.62M |
Total Liabilities | 25.12M | 31.71M | 36.09M | 33.68M | 201.41M | 139.36M | 281.19M | 230.26M | 226.45M |
Total Debt | 14.6M | 12.96M | 16.5M | 14.69M | 5.29M | 52K | 131.53M | 86.89M | 79.34M |
Common Stock | 9K | 4K | 4K | 4K | 4K | 4K | 14K | 14K | 14K |
Retained Earnings | -422.5M | -431.6M | -433.68M | -427.51M | -591.62M | -423.15M | -474.84M | -422.28M | -403.1M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -11.32M | -28.57M | -32.09M | -27.95M | -198.38M | -121.74M | -287.5M | -234.94M | -215.76M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |